Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

Arnon P. Kater, Mark‐David Levin, Jeanette K. Doorduijn et al.|Haematologica|2018

Cited by 13